NSE filing, NSE: ARISTO. Summary written from the filing by ALFA Finder's alert engine.
Aristo Bio-Tech and Lifescience Ltd: key numbers
- Share price
- ₹86.00
- Market cap
- ₹58.55 Cr
- Revenue (annual)
- ₹363.7 Cr
- Net profit (annual)
- ₹7.18 Cr
- P/E (TTM)
- 8.2×Sector 34.1×
- Promoter holding
- 73.42%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aristo Bio-Tech and Lifescience Ltd
All →Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered and voted on routine items including financial statements and director appointments.
Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited has issued a notice for its 21st Annual General Meeting to be held on September 30, 2026.
Aristo Bio-Tech and Lifescience Board Meeting Outcome
Aristo Bio-Tech declared a final dividend of Rs. 0.60 per share and approved re-appointments for directors and the cost auditor.
Aristo Bio-Tech and Lifescience H2 FY26 Results: Turns Profitable, Net Profit ₹3 Cr
Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.
- Key figure
- Net profit ₹3 Cr
Aristo Bio-Tech and Lifescience Financial Results
Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.
Aristo Bio-Tech and Lifescience Other Announcement
Aristo Bio-Tech submitted its annual SDD compliance certificate for FY 2025-26. The certificate confirms maintenance of the mandatory structured digital database for insider trading monitoring.
Other other announcement announcements
All →Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Teja Engineering Industries Other Announcement
Teja Engineering Industries filed a non-applicability certificate for Reg 27(2) Corporate Governance for Q1 FY27. As an NSE Emerge-listed SME, the company is exempt from this periodic disclosure.
Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.